Filing Details
- Accession Number:
- 0000899243-23-005523
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-02-17 18:40:24
- Reporting Period:
- 2022-12-08
- Accepted Time:
- 2023-02-17 18:40:24
- Original Submission Date:
- 2022-12-12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1841387 | Candel Therapeutics Inc. | CADL | Biological Products, (No Disgnostic Substances) (2836) | 522214851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1873465 | Christopher Martell | C/O Candel Therapeutics, Inc. 117 Kendrick St., Suite 450 Needham MA 02494 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-08 | 3,050 | $1.68 | 128,050 | No | 4 | P | Indirect | By GTAM1 2012 LLC |
Common Stock | Acquisiton | 2022-12-09 | 23,950 | $1.92 | 152,000 | No | 4 | P | Indirect | By GTAM1 2012 LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By GTAM1 2012 LLC |
No | 4 | P | Indirect | By GTAM1 2012 LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 283,514 | Indirect | By GTAM1 2012 ADV LLC |
Footnotes
- The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.88 to $1.98. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
- Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.